|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03886 TOWN HEALTH
Nominal 
0.255 0.000 (0.000%) | 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Turnover | 1,833,795 | 0.041% | 1,833,038 | 1,535,580 | 1,483,892 | 1,069,045 |
| Cost of Sales | (1,346,406) | 1.151% | (1,331,090) | (1,121,134) | (1,012,631) | (784,465) |
| Gross Profit | 487,389 | -2.900% | 501,948 | 414,446 | 471,261 | 284,580 |
| 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | (207,693) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | (117,763) | -- | |
| Share of Results of Asso. & JCEs | (7,155) | 34.518% | (5,319) | (14,826) | 32,844 | 4,181 | |
| Profit / (Loss) before Taxation | (121,691) | 0.685% | (120,863) | 82,503 | 126,508 | (232,855) | |
| Taxation | (36,516) | -4.473% | (38,226) | (32,981) | (51,436) | (25,595) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (45,496) | 29.541% | (35,121) | (34,233) | (53,059) | (22,588) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (203,703) | 4.888% | (194,210) | 15,289 | 22,013 | (281,038) | |
| 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Net Finance Costs / (Income) | (12,664) | 52.873% | (8,284) | (16,809) | (12,425) | (39,391) |
| Depreciation & Amortisation | 136,662 | -6.157% | 145,629 | 127,560 | 122,221 | 133,980 |
| Directors' Emoluments | 11,745 | -27.054% | 16,101 | 12,805 | 3,751 | 504 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -3.010 | 4.878% | -2.870 | 0.210 | 0.290 | -3.730 |
| DPS (cts) | 0.120 | -- | 0.120 | 0.120 | 0.150 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | 57.143% | 51.724% | -- |
| Cash flow per share ($) | -- | -- | 0.037 | 0.006 | 0.023 | 0.004 |
| NBV per share ($) | 0.439 | -- | 0.479 | 0.511 | 0.512 | 0.506 |
| Remarks: | Real time quote last updated: 16/04/2025 17:22 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -203,703 |
| %Change | 4.888% |
| EPS / (LPS) | HKD -0.030 |
| NBV Per Share ($) | HKD 0.439 |